Testing a new melasma treatment with TGF Beta 3
Treatments studied
Part of Skin clinical trials.
This trial tests a treatment called Secretome TGF Beta 3 for women with melasma. It aims to see if this treatment can improve dark patches on the skin.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman between 30 and 60 years old.
- You have melasma (dark patches on your face).
- Your skin type is Fitzpatrick type IV or V (olive to brown skin).
- You are not pregnant or breastfeeding.
- You have not used certain skin lightening creams or treatments in the past few weeks.
- You do not have other skin conditions that affect pigmentation.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a cream made from stem cell secretions to see if it can help reduce melasma (dark patches on the face). It may be an option for women who haven't improved with other treatments.
This trial tests two different triple-combination creams for melasma in women with skin types IV or V. Both creams contain a bleaching agent and a retinoid, but one uses a different steroid. The goal is to see which is safer and works better.
This study tests a new gel (SM-030) for adults with moderate to severe melasma. If you join, you would use the gel on your face for a few months and stop other skin-lightening products, while applying the provided sunscreen every day.
This trial tests two injectable treatments for melasma (dark patches on the face): platelet-rich fibrin, which uses your own blood cells to promote healing, and tranexamic acid, a medication that may reduce pigmentation. The study will compare which works better for women with mild to moderate melasma.
This trial tests if adding MelaB3 serum to a 35% glycolic acid peel works better than the peel alone for treating dark spots caused by melasma, acne scars, or sun damage. It may be a good option if you have mild to moderate dark spots and are willing to avoid sun exposure and other skin-lightening products.
This trial tests whether a cream containing metformin or tranexamic acid can reduce melasma (dark patches on the face). It aims to see which treatment works better.
Hear when a new Melasma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.